A detailed history of Cwm, LLC transactions in Alector, Inc. stock. As of the latest transaction made, Cwm, LLC holds 3,844 shares of ALEC stock, worth $7,149. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,844
Previous 434 785.71%
Holding current value
$7,149
Previous $2,000 800.0%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$4.34 - $6.58 $14,799 - $22,437
3,410 Added 785.71%
3,844 $18,000
Q2 2024

Jul 09, 2024

SELL
$4.19 - $6.23 $1,244 - $1,850
-297 Reduced 40.63%
434 $2,000
Q1 2024

Apr 05, 2024

BUY
$5.69 - $8.08 $3,590 - $5,098
631 Added 631.0%
731 $4,000
Q4 2023

Feb 01, 2024

SELL
$3.77 - $8.39 $614 - $1,367
-163 Reduced 61.98%
100 $1,000
Q3 2023

Oct 11, 2023

BUY
$5.2 - $8.77 $561 - $947
108 Added 69.68%
263 $2,000
Q2 2023

Aug 03, 2023

BUY
$5.86 - $7.93 $322 - $436
55 Added 55.0%
155 $1,000
Q4 2022

Feb 01, 2023

SELL
$6.88 - $9.55 $2,752 - $3,820
-400 Reduced 80.0%
100 $1,000
Q2 2020

Sep 15, 2021

BUY
$21.87 - $33.11 $8,748 - $13,244
400 Added 400.0%
500 $10,000
Q2 2020

Jul 22, 2020

SELL
$21.87 - $33.11 $8,748 - $13,244
-400 Reduced 80.0%
100 $2,000
Q1 2020

Sep 15, 2021

BUY
$16.25 - $35.28 $6,500 - $14,112
400 Added 400.0%
500 $10,000
Q1 2020

Apr 28, 2020

SELL
$16.25 - $35.28 $6,500 - $14,112
-400 Reduced 80.0%
100 $2,000
Q4 2019

Sep 14, 2021

BUY
$14.17 - $20.3 $5,668 - $8,120
400 Added 400.0%
500 $10,000
Q4 2019

Jan 27, 2020

SELL
$14.17 - $20.3 $5,668 - $8,120
-400 Reduced 80.0%
100 $2,000
Q3 2019

Sep 14, 2021

BUY
$14.42 - $22.2 $7,210 - $11,100
500 New
500 $10,000
Q3 2019

Oct 22, 2019

SELL
$14.42 - $22.2 $7,210 - $11,100
-500 Closed
0 $0
Q2 2019

Sep 14, 2021

BUY
$16.26 - $26.42 $8,130 - $13,210
500 New
500 $10,000
Q2 2019

Jul 31, 2019

SELL
$16.26 - $26.42 $8,130 - $13,210
-500 Closed
0 $0
Q1 2019

Sep 02, 2021

BUY
$15.97 - $22.5 $7,985 - $11,250
500 New
500 $0

Others Institutions Holding ALEC

About Alector, Inc.


  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $154M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.